Cytopia
Richmond
About Cytopia
Cytopia's mission is to develop targeted small molecule therapeutics for cancer. The company also aims to develop drugs for other diseases with unmet medical need including immune conditions, such as organ transplant rejection. Through its internal discovery and development expertise, Cytopia has devised a portfolio of drug candidates at various stages of formal development.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Website: cytopia.com.au
- Phone: 61-3-9208-4222
Canonical: https://fsome.com/organization/cytopia-2140366 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.